Literature DB >> 2600981

Investigation on the inhibitory effect of tumor-derived immunosuppressive factor(s) on T lymphocyte proliferation.

R D Wang, Z H Feng, Y Luo, Z C Chen.   

Abstract

Using five tumor cell lines, the effect of tumor-derived immunosuppressive factor(s) (TDSF) on T lymphocyte proliferation and its mechanism have been investigated. It was found that TDSF markedly inhibited PHA-stimulated T lymphocyte proliferation via a noncytotoxic mechanism. The inhibition increased in dose-dependent manner and the maximum inhibition was achieved when the factor was added at the initiation of the culture. When PBMC were preincubated with supernatants of tumor cells for 24 h, washed extensively and then cocultured with freshly prepared PBMC, similar suppressive effects were observed. The above results indicated that the activation of any suppressor cell subgroup may be one of the mechanisms of immunosuppressive action of TDSF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600981     DOI: 10.1007/bf02908963

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  6 in total

1.  Purification of soluble human melanoma-associated antigens.

Authors:  J A Roth; H K Slocum; M A Pellegrino; E C Holmes; R A Reisfeld
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

2.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

3.  Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.

Authors:  S K Oh; F L Moolten
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  Radiosensitive, thymic hormone-sensitive peripheral blood suppressor cell activity in cancer patients.

Authors:  E M Hersh; Y Z Patt; S G Murphy; K Dicke; A Zander; M Adegbite; R Goldman
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

5.  Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.

Authors:  L L Perry; B Benacerraf; M I Greene
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

6.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.